Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer?

Breast

Volumn 15, Issue 3, 2006, Pages 355-362

  Lê, Monique G ^a   Arriagada, Rodrigo ^a,b   Bahi, Jacqueline ^a,c   Pfeiffer, Frédérique ^a   Cammoun, Mohamed ^c   Tabbane, Françoise ^c   Rubino, Carole ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c SALAH AZAIEZ INSTITUTE   (Tunisia)

Author keywords

Breast feeding duration; Case only study; Inflammatory breast cancer; Reproductive risk factors

Indexed keywords

ADULT; ARTICLE; BODY MASS; BREAST CANCER; BREAST FEEDING; CANCER PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATION; FEMALE; FRANCE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; TUNISIA;

EID: 33744804041     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.08.018     Document Type: Article

References (28)

1. Chang S., Parker S.L., Pham T., Buzdar A.U., and Hursting S.D. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute. Cancer 82 (1998) 2366-2372
2. Jaiyesimi I.A., Buzdar A., and Hortobagyi G. Inflammatory breast cancer: a review. J Clin Oncol 10 (1992) 1014-1024
3. Chang S., Buzdar A.U., and Hursting S.D. Inflammatory breast cancer and body mass index. J Clin Oncol 16 (1998) 3731-3735
4. Lê MG, Arriagada R, Contesso G, et al. Dermal lymphatic emboli in inflammatory breast cancer: a French-Tunisian joint study in 337 patients. Clin Breast Cancer 2005; in press.
5. Denoix P. Treatment of malignant breast tumors. In: Berlib, and Rentchnick P. (Eds). Recent results in cancer research vol. 31 (1970), Springer, Berlin 3-11
6. Ellis D.L., and Teitelbaum S. Inflammatory carcinoma of the breast: a pathologic definition. Cancer 33 (1974) 1045-1047
7. Saltzstein S.L. Clinically occult inflammatory carcinoma of the breast. Cancer 34 (1974) 382-388
8. Lucas F.V., and Perez-Mesa C. Inflammatory carcinoma of the breast. Cancer 41 (1978) 1595-1605
9. Dixon W.J. BMDP statistical software (1988), University of California Press, Berkeley, CA
10. Leitch A. Peau d'orange in acute mammary carcinoma: its cause and diagnostic value. Lancet 2 (1909) 861-863
11. Lee B.J., and Tannenbaum N.E. Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of the Memorial Hospital. Surg Gynecol Obstet 39 (1924) 580-595
12. Haagensen C.D. Inflammatory carcinoma. Diseases of the breast. 2nd ed (1971), W B Saunders Co., Philadelphia 576-585
13. Levine P.H., Steinhorn S.C., Gloecker Ries L., and Aron J. Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) Program. J Natl Cancer Inst 74 (1985) 291-297
14. Gilchrist K.W., Gould V.E., Hirschl S., et al. Interobserver variation in the identification of breast carcinoma in intramammary lymphatics. Hum Pathol 13 (1982) 170-172
15. Wilke D., Colwell B., and Dewar R. Inflammatory breast carcinoma: comparison of survival of those diagnosed clinically, pathologically, or with both features. Am Surg 64 (1998) 428-431
16. Amparo R.S., Angel C.D.M., Ana L.H., et al. Inflammatory breast carcinoma: pathological or clinical entity?. Breast Cancer Res Treat 64 (2000) 269-273
17. Gruber G., Ciriolo M., Altermatt H.J., Aebi S., Berclaz G., and Greiner R.H. Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer. Int J Cancer 109 (2004) 144-148
18. Bonnier P., Charpin C., Lejeune C., et al. Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?. Int J Cancer 62 (1995) 382-385
19. Costa J., Webber B.L., Levine P.H., et al. Histopathological features of rapidly progressing breast carcinoma in Tunisia: a study of 94 cases. Int J Cancer 30 (1982) 35-37
20. Tabbane F., Bahi J., Rahal K., et al. Inflammatory symptoms in breast cancer. Correlations with growth rate, clinicopathologic variables and evolution. Cancer 64 (1989) 2081-2089
21. Anderson W.F., Chu K.C., and Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?. J Clin Oncol 21 (2003) 2254-2259
22. Bernier M.O., Plu-Bureau G., Bossard N., Ayzac L., and Thalabard J.C. Breastfeeding and risk of breast cancer: a meta-analysis of published studies. Hum Reprod 6 (2000) 374-386
23. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet 360 (2002) 187-195
24. Anderson W.F., Chu K.C., and Sherman M.E. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 13 (2004) 1128-1135
25. Hartge P., Chatterjee N., Wacholder S., Brody L.C., Tucker M.A., and Struewing J.P. Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history. Epidemiology 13 (2002) 255-261
26. Ingram J., Hunt L., Woolridge M., and Greenwood R. The association of progesterone, infant formula use and pacifier use with the return of menstration in breastfeeding women: a prospective cohort study. Eur J Obstet Reprod Biol 114 (2004) 197-202
27. Wingo P.A., Jamison P.M., Young J.L., and Gargiullo P. Population-based statistics for women diagnosed with inflammatory breast cancer. Cancer Cause Control 15 (2004) 321-328
28. Ursin G., Bernstein L., Wang Y., et al. Reproductive factors and risk of breast carcinoma in a study of white and African-American women. Cancer 101 (2004) 353-362